how does semaglutide work for weight loss HealthMatters | What is semaglutide—and

The STEP UP trial, a Phase 3b study published in The Lancet Diabetes & Endocrinology in 2025, evaluated a 7.2 mg weekly injection dose in over 1,400 adults with obesity (BMI of 30 or higher) and without diabetes

can help explain why these medications are transforming obesity treatment and metabolic health

But users can get it from doctors for other uses, or buy it on e-commerce platforms such as Taobao and JD.com (JD) with other peoples prescriptions

For context, the semaglutide journey from Phase 3 initiation to market availability in smaller European markets took roughly 45 years

63 In a large-scale real-world study, the use of GLP-1 receptor agonists in patients with T2DM was also shown to increase the risk of intestinal obstruction compared to sodiumglucose cotransporter-2 (SGLT-2) inhibitors

lets find the right solution together